Doctors are sounding the alarm about a possible drug-resistant health crisis in the future after a number of antibiotic manufacturers have gone bankrupt, reports The New York Times. The timing comes as more and more bacteria are growing resistant to traditional antibiotics, and there is a greater need than ever for companies to innovate against future superbugs.
“This is a crisis that should alarm everyone,” said Dr. Helen Boucher, an infectious disease specialist at Tufts Medical Center.
Two antibiotic startups, Achaogen and Aradigm, closed their doors in the past few months, and one of the biggest developers of antibiotic drugs, Melinta Therapeutics, also admitted that it was suffering from a cash flow problem and nearing insolvency. The company’s stock price dropped by 45 percent as a result of the announcement.
0 comments :
Post a Comment